These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cellular reprogramming by transcription factor engineering. Tsang JC; Gao X; Lu L; Liu P Curr Opin Genet Dev; 2014 Oct; 28():1-9. PubMed ID: 25151337 [TBL] [Abstract][Full Text] [Related]
3. Current status in cancer cell reprogramming and its clinical implications. Izgi K; Canatan H; Iskender B J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745 [TBL] [Abstract][Full Text] [Related]
4. Cellular reprogramming and cancer development. Semi K; Matsuda Y; Ohnishi K; Yamada Y Int J Cancer; 2013 Mar; 132(6):1240-8. PubMed ID: 23180619 [TBL] [Abstract][Full Text] [Related]
5. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling? Yilmazer A; de Lázaro I; Taheri H Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716 [TBL] [Abstract][Full Text] [Related]
6. Application of iPS cell technology to cancer epigenome study: uncovering the mechanism of cell status conversion for drug resistance in tumor. Matsuda Y; Semi K; Yamada Y Pathol Int; 2014 Jul; 64(7):299-308. PubMed ID: 25047500 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation leading to induced pluripotency drives cancer development in vivo. Ohnishi K; Semi K; Yamada Y Biochem Biophys Res Commun; 2014 Dec; 455(1-2):10-5. PubMed ID: 25019993 [TBL] [Abstract][Full Text] [Related]
8. Tumoral reprogramming: Plasticity takes a walk on the wild side. Campos-Sánchez E; Cobaleda C Biochim Biophys Acta; 2015 Apr; 1849(4):436-47. PubMed ID: 25038581 [TBL] [Abstract][Full Text] [Related]
9. Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells. Knappe N; Novak D; Weina K; Bernhardt M; Reith M; Larribere L; Hölzel M; Tüting T; Gebhardt C; Umansky V; Utikal J Stem Cells; 2016 Apr; 34(4):832-46. PubMed ID: 26753613 [TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell technology for dissecting the cancer epigenome. Semi K; Yamada Y Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327 [TBL] [Abstract][Full Text] [Related]
11. Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology. Laplane L; Beke A; Vainchenker W; Solary E Stem Cells; 2015 Oct; 33(10):2887-92. PubMed ID: 26179060 [TBL] [Abstract][Full Text] [Related]